Common carotid artery cannulation can provide antegrade blood flow to the whole body during cardiopulmonary bypass, as well as maintain cerebral perfusion even at the time of arch exclusion or repair.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Extracorporeal circulation
March 19, 2018
March 12, 2018
An interesting two-year report from the MOMENTUM 3 randomized controlled trial comparison of HeartMate 3 and II, the analysis performed by Abbott. Although stroke and reoperation were clearly lower with the latest technology, reflected in the lower LDH measurements, there was bafflingly no improvement in survival.
February 21, 2018
A well-written, brief, pessimistic editorial on the loss of surgeon autonomy in innovation.
February 8, 2018
Mark Bennett of the Southwest Cardiothoracic Unit in Plymouth, UK, discusses biomarkers for problems during cardiopulmonary bypass.
February 6, 2018
The authors conducted a prospective randomized study of 20 high-risk cardiac surgical patients, split into two groups: pulsatile versus nonpulsatile flow during cardiopulmonary bypass. Using spectral imaging and near-infrared technology, the group found that the the pulsatile perfusion group maintained better perfusion indices in the microcirculati
January 2, 2018
A sobering editorial, read last May at the AATS, that discusses at length the ethics of ventricular assist as a super expensive therapy seen from the principle of fairness.
December 6, 2017
Research published recently in the European Journal of Cardio-Thoracic Surgery analyzed the outcomes of elderly cardiac surgery patients to evaluate whether minimally invasive extracorporeal circuits conferred a benefit over conventional cardiopulmonary bypass.
November 23, 2017
Jonathan Anderson of Hammersmith Hospital in London, UK, argues that surgeons should be interested in the effect that cardiopulmonary bypass has on a patient.
November 16, 2017
The incoming issue of the Journal comes with an interesting group of papers revolving around a provocative topic: work from Seattle on the absence of predictive value of standard pulmonary function tests in LVAD surgery. Vivek Rao takes the opportunity to present his thoughts in this brief editorial, the important central message of which cannot be
November 16, 2017
An enthusiastic yet balanced and succinct editorial on the occasion of a small series with short follow-up and absolute survival of ECMO-supported recipients of pulmonary transplantation (mostly with interstitial fibrosis) with short waiting time after ECMO (less than 16 days).